Remove Collaboration Remove Negotiation Remove Pharmaceutical
article thumbnail

Unleashing Synergy: A Guide to Strategic Integration and Value Amplification for Internal Business Groups

Devensoft

Unlike traditional external collaborations, where integration efforts may be outsourced or guided by external consultants, the internal integration model places the reins of control squarely within the capable hands of the organization itself. This blueprint serves as a roadmap for the entire integration journey.

article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Managing Product Shortages through Strategic M&A: Building a Resilient Supply Chain

Sun Acquisitions

Larger, consolidated companies can negotiate better terms with suppliers, secure more favorable contracts, and reduce per-unit production costs. By acquiring a supplier, businesses can ensure greater control over the supply chain, improving collaboration and communication.

M&A 52
article thumbnail

The SaaS Prescription: Healthcare Trends and M&A Insights

Software Equity Group

A shift to patient-centered care A growing body of research and consumer demand are pushing healthcare organizations to adopt a more personalized, collaborative, comprehensive approach to caring for patients’ whole-health needs.

article thumbnail

The SaaS Prescription: Healthcare Trends and M&A Insights

Software Equity Group

A shift to patient-centered care A growing body of research and consumer demand are pushing healthcare organizations to adopt a more personalized, collaborative, comprehensive approach to caring for patients’ whole-health needs.

article thumbnail

Antitrust Trends to Look Out for in 2022

Cooley M&A

Additionally, ESG initiatives – which Biden has promoted over the past year – may require navigation around antitrust issues regarding competitor collaborations. Congress targets pharmaceutical industry pricing and business practices. Indeed, the FTC has started inquiring about ESG practices in investigating mergers.